Mechanically, we further demonstrated that the overexpressed TRIM9 increased tumor cells proliferation, migration and drug resistance via CEACAM6-Smad2/3 signaling activation in bladder cancer. Here, TRIM9 is linked to urinary bladder carcinoma.